Nov 12, 2018 7:00 am EST Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial
Nov 08, 2018 7:00 am EST Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference
Nov 06, 2018 7:00 am EST Capricor Therapeutics to Present Third Quarter Financial Results and Corporate Update on November 13
Nov 02, 2018 7:00 am EDT Capricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6
Aug 21, 2018 7:00 am EDT Capricor Therapeutics Presents Results of Studies of CAP-2003 at Gordon Research Conference on Extracellular Vesicles
Aug 09, 2018 4:00 pm EDT Capricor Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 02, 2018 4:00 pm EDT Capricor Therapeutics to Present Second Quarter Financial Results and Corporate Update on August 9
Jul 17, 2018 7:00 am EDT Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops